17Jun 2019

BREAST CANCER IN YOUNG MOROCCAN WOMEN UNDER AGE OF 40 YEARS, A RETROSPECTIVE STUDY.

  • Department of Radiotherapy Oncology, Mohammed V Military teaching Hospital. Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Morocco.
  • Department of gynecology, Mohammed V Military teaching Hospital. Rabat, Morocco.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Purpose: This study aimed at evaluating the epidemiological, clinical, pathological and therapeutic characteristics of breast cancer in young Moroccan women. Patients and methods: About 60 cases of breast cancer in young women under the age of forty, haves been admitted at the radiation service of the military hospital Mohammed V of Rabat for the period starting from 01 January 2010 and ending at 31 December 2015. Results: The frequency of breast cancer in young women who were under 40 years old was about 18.5%. The average age was 35 years. About 25% of theme had a family history of breast cancer. Tumors classified T2 were the most frequent (numerically 45%), followed by T1 tumors (31.7%). N0 forms were the most common (76.6%) followed by N1 forms (18.3%). Regarding anatomopathological aspect, the invasive ductal carcinoma has been the most frequently, noticed in 90.1%, SBR II in 57% and SBR III in 34%. Hormone receptors were positive in 66.6% of cases and HER2 over-expressed in 35% of cases. In regard to therapeutic plan, all patients had undergone surgical treatment, which was identified as radical in about 66.7% of cases and conservative in 33.3%. The radiotherapy has been delivered to 59 patients and the chemotherapy has been prescribed for 57 patients. The hormonotherapy has been prescribed for 40 patients and monoclonal antibody trastuzumab for only 19 patients. The overall 3-years survival rate was found to be 92.1%. Conclusion: The incidence of breast cancer in young Moroccan women is so high; this could be explained by the existence of familial medical history and genetic forms. Our study confirms the data found in the literature advocating more advanced forms and worse prognosis of breast cancer in young patients. An improvement of this prognosis could be obtained after the implementation of a cancer screening program, in young women having a potential risk factor to suffer a breast cancer, followed by a well-adapted medical care taking into account the known prognostic factors.

  1. Anders CK et al (2009): Breast cancer before age 40 years. Semin Oncol. 36(3):237-49.
  2. Antoniou A. et al (2003): Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies.The American Journal of Human Genetics, 72(5): p. 1117-1130.
  3. Bakkali H, et al (2003)?: Le cancer du sein chez la femme de 30 ans et moins. Cancer Radiother;7:153?9.
  4. Balu-Maestro C. et al (2010)?: D?pistage du cancer du sein: quelle imagerie pour quelles femmes? Journal de Gyn?cologie Obst?trique et Biologie de la Reproduction, 39(1): p. 3-10.
  5. Boisserie-Lacroix M. et al (2006): ?chographie du sein: nouvelles approches. Gyn?cologie obst?trique & fertilit?, 34(12): p. 1170-1177.
  6. Botteri E. et al (2010): Axillary lymph node involvement in women with breast cancer: does it depend on age? Clinical breast cancer, 10(4): 318-321.
  7. Boufettal H, et al( 2010)?: Cancer du sein chez la femme jeune au Maroc. Cancer Radiother. 14:698?703.
  8. Bouzid N. et al (2013)?: Cancer du sein chez la femme jeune de moins de 35 ans en Tunisie: ?tude r?trospective ? propos de 124 cas. Gyn?cologie Obst?trique & Fertilit?.?; 41(6): 356-360.
  9. Cancello G et al (2010): Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (< 35 years) with operable breast cancer. Ann Oncol 21(10):1974?81.
  10. Cancer, C.G.o.H.F.i.B., (2001): Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. The Lancet,; 358(9291):1389-1399.
  11. Cancers du sein (2007): recommandations pour la pratique clinique de Saint Paul de Vence. Oncologie;9:593?644
  12. Chung M, et al (1996)?: Younger women with breast carcinoma have a poorer prognosis than older women. Cancer;77: 97?103.
  13. Colleoni M et al (2002): Very young women (< 35 years) with operable breast cancer: features of disease at presentation. Ann Oncol. 13:273?9.
  14. Espi? M, H.Cottu. (2003): Cancer du sein de la femme jeune: probl?mes et questions. Pathologie Biologie; 51(7): 391-392.
  15. Ewertz M. et al (1990): Age at first birth, parity and risk of breast cancer: A meta‐analysis of 8 studies from the nordic countries. International journal of cancer.; 46(4): 597-603.
  16. Ferlay J. et al. GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 . Lyon: IARC. 2013.
  17. Foxcroft LM, et al (2004)?: The diagnosis of breast cancer in women younger than 40. Breast;13:297?306
  18. Greater Casablanca cancer registry report 2007 (French)?2004?Available at:http://www.contrelecancer.ma/site_media/uploaded_files/Registre_des_Cancers_de_la_Re%C3%BCgion_du_grand_Casablanca_2004.pdf. Accessed 10 May 2013.
  19. Group, E.B.C.T.C. (2011), Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. The lancet,. 378(9793): p. 771-784.
  20. Guendouz H. et al (2011)?: Cancer du sein de la femme de moins de 35 ans: ?tude r?trospective ? propos de 612 cas. Soci?t? fran?aise de s?nologie et de pathologie mammaire. La Lettre du s?nologue.
  21. Haas J.A. et al (1998)?: An analysis of age and family history on outcome after breast-conservation treatment: the University of Pennsylvania experience. The cancer journal from Scientific American, 4(5): p. 308-315.
  22. Hunter D.J. et al (2010): Oral contraceptive use and breast cancer: a prospective study of young women.Cancer Epidemiol Biomarkers Prev. 19(10):2496-2502.
  23. Johnstone P.A. et al (2001): Yield of mammography in selected patients age≤ 30 years. Cancer,. 91(6): p. 1075-1078.
  24. Kerlikowske K. et al (2000): Performance of screening mammography among women with and without a first-degree relative with breast cancer. Annals of Internal Medicine, 133(11): p. 855-863.
  25. Khanfir A, al (2006): Le cancer du sein de la femme jeune dans le sud tunisien. Cancer Radiother. 10:565?71.
  26. Kolb T.M., et al (2002): Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology,. 225(1): p. 165-175.
  27. Kothari AS (2002)?: Breast carcinoma in women aged 25 years or less. Cancer;94:606?14.
  28. Kumle, M. et al. Use of oral (2002): contraceptives and breast cancer risk: The Norwegian-Swedish Women?s Lifestyle and Health Cohort Study. Cancer Epidemiology and Prevention Biomarkers.; 11(11): 1375-1381.
  29. Lee CG, et al (1992): Infiltrating breast carcinoma in patients aged 30 years and younger: long-term outcome for life, relapse, and second primary tumors. Int J Radiat Oncol Biol Phys;23:969?75.
  30. Maggard MA, et al (2003): Do young breast cancer patients have worse outcomes? J Surg Res, 113:109?13.
  31. Mathews RH, et al (1988)?: Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. Int J Radiat Oncol Biol Phys. 14:659?63
  32. Peto J. et al (1999): Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. Journal of the National Cancer Institute. 91(11): p. 943-949.
  33. Rochefordiere A, al (1993): Age as prognosis factor in premenopausal breast carcinoma. Lancet 341: 1039?43.
  34. G?etal.Salmon(2008)?:R?sultats?carcinologiques?et?esth?tiques?du?traitement?du?cancer?du?sein?par?plastie?mammaire. 298 cas. Annales de Chirurgie Plastique?Esth?tique. 53(2): 124-134.
  35. Voogd, A.C., et al(2001): Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. Journal of clinical oncology,. 19(6): p. 1688-1697.
 

[Khalid Andaloussi-Saghir, Khalid Hadadi, Abdelhamid Benlghazi, jaafar Bakkali, Mohamed Elmarjany, Abdelhak Maghous, Amine Marnouch, Hamid Mansouri and Hassan Sifat. (2019); BREAST CANCER IN YOUNG MOROCCAN WOMEN UNDER AGE OF 40 YEARS, A RETROSPECTIVE STUDY. Int. J. of Adv. Res. 7 (Jun). 639-648] (ISSN 2320-5407). www.journalijar.com

Khalid Andaloussi Saghir
Department of Radiotherapy Oncology, Mohammed V Military teaching Hospital.

DOI:

Article DOI: 10.21474/IJAR01/9266      
DOI URL: https://dx.doi.org/10.21474/IJAR01/9266

Download Full Paper

Download PDF No. of Downloads: 29 | No. of Views: 91